Table 1.
Study population.
| Ultramag® | Mag2® | |
|---|---|---|
| Patients | 27 | 16 |
| Drop out | 0 | 3 |
| Age range (Years) | 47 (22–72) | 52 (35–82) |
| Female | 9 (33.3%) | 5 (38.4%) |
| Male | 18 (66.6%) | 8 (61.6%) |
| Patients in triple immunosuppressive therapy | 26 (96%) | 12 (92%) |
| Patients in double immunosuppressive therapy | 1 (4%) | 1 (8%) |
| Dose of Mg | 375 mg (1 sachet) | 370 mg (3 vials) |
| Baseline Mg levels | 0.60 ± 0.02 mmoL/L (1.46 ± 0.05 mg/dl) |
0.61 ± 0.05 mmol/L (1.48 ± 0.12 mg/dL) |
| Side effects | 1 patient (nausea) |
6 patients (3 of them dropped out for diarrhea) and 1 had nausea |